ArticleInternational journal of hematology-oncology and stem cell research2015

Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patients.

Ehsan Mohajeri et al.PubMed ↗Full text ↗

No numbers read from the abstract.